Henry F. Chambers

SCIENTIFIC ADVISOR
Pharmaceutical
TAXIS Pharmaceuticals
United States of America

Biography

Dr. Chambers has been a member of the medical faculty at the University of California San Francisco (UCSF) for more than 30 years, where he is a professor of medicine and served as Chief of Infectious Diseases at San Francisco General Hospital from 1992-2013 and Director of the UCSF Infectious Diseases Fellowship Training Program from 2002-2013. He is a Fellow of the Infectious Diseases Society of America (IDSA) and of the American College of Physicians. He was also elected to the American Society of Clinical Investigation and the American Association of Physicians. He serves as editor for the Stanford Guide to Antimicrobial Therapy and has authored more than 200 original publications and textbook chapters in the areas of drug resistance, endocarditis, bacterial infections and staphylococcal diseases. He served as a member of advisory groups for the Centers for Diseases Control and Prevention, a member of the IDSA treatment guidelines committee for skin and soft tissue infections, and co-chaired the IDSA guidelines committee for treatment of methicillin-resistant Staphylococcus aureus infections. His clinical and research interests include antimicrobial drug resistance, staphylococcal infections, experimental therapeutics, and epidemiology and pathogenesis of disease caused by community methicillin-resistant Staphylococcus aureus. Dr. Chambers received his B.A. from Centre College in Kentucky and earned his M.D. in Medicine from the Vanderbilt University School of Medicine, where he was class valedictorian. He completed training in Internal Medicine and Infectious Diseases at the University of California San Francisco. Dr. Chambers has been a member of the medical faculty at the University of California San Francisco (UCSF) for more than 30 years, where he is a professor of medicine and served as Chief of Infectious Diseases at San Francisco General Hospital from 1992-2013 and Director of the UCSF Infectious Diseases Fellowship Training Program from 2002-2013. He is a Fellow of the Infectious Diseases Society of America (IDSA) and of the American College of Physicians. He was also elected to the American Society of Clinical Investigation and the American Association of Physicians. He serves as editor for the Stanford Guide to Antimicrobial Therapy and has authored more than 200 original publications and textbook chapters in the areas of drug resistance, endocarditis, bacterial infections and staphylococcal diseases. He served as a member of advisory groups for the Centers for Diseases Control and Prevention, a member of the IDSA treatment guidelines committee for skin and soft tissue infections, and co-chaired the IDSA guidelines committee for treatment of methicillin-resistant Staphylococcus aureus infections. His clinical and research interests include antimicrobial drug resistance, staphylococcal infections, experimental therapeutics, and epidemiology and pathogenesis of disease caused by community methicillin-resistant Staphylococcus aureus. Dr. Chambers received his B.A. from Centre College in Kentucky and earned his M.D. in Medicine from the Vanderbilt University School of Medicine, where he was class valedictorian. He completed training in Internal Medicine and Infectious Diseases at the University of California San Francisco.

Research Intrest

Infectious Diseases